Cargando…
Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy
AIM: To determine the effect of insulin on the resistance of subcutaneous tissue to the flow of infusion fluids. MATERIALS AND METHODS: Thirty subjects with type 1 diabetes wore two Accu‐Chek Spirit Combo insulin pumps with Accu‐Chek FlexLink infusion sets (Roche Diabetes Care, Mannheim, Germany) fo...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299465/ https://www.ncbi.nlm.nih.gov/pubmed/34739179 http://dx.doi.org/10.1111/dom.14594 |
_version_ | 1784750981668405248 |
---|---|
author | Regittnig, Werner Tschaikner, Mathias Tuca, Alexandru‐Cristian Simic, Amra Feiel, Jürgen Schaller‐Ammann, Roland Licht, Alexander H. Jungklaus, Miró Pieber, Thomas R. |
author_facet | Regittnig, Werner Tschaikner, Mathias Tuca, Alexandru‐Cristian Simic, Amra Feiel, Jürgen Schaller‐Ammann, Roland Licht, Alexander H. Jungklaus, Miró Pieber, Thomas R. |
author_sort | Regittnig, Werner |
collection | PubMed |
description | AIM: To determine the effect of insulin on the resistance of subcutaneous tissue to the flow of infusion fluids. MATERIALS AND METHODS: Thirty subjects with type 1 diabetes wore two Accu‐Chek Spirit Combo insulin pumps with Accu‐Chek FlexLink infusion sets (Roche Diabetes Care, Mannheim, Germany) for 7 days. One pump was filled with insulin aspart (Novo Nordisk, Bagsvaerd, Denmark) and used for continuous subcutaneous insulin infusion (CSII). The other pump was filled with insulin diluting medium (IDM; Novo Nordisk) and used to deliver IDM subcutaneously at rates identical to those employed for CSII. Both infusion sites were assessed daily by measuring the pressure required to infuse various bolus amounts of IDM. RESULTS: On day 1, maximum pressure (P(max)) and tissue flow resistance (TFR; calculated from measured pressure profiles) were similar for both infusion sites (P > 0.20). During the subsequent study days, the P(max) and TFR values observed at the IDM infusion site remained at levels comparable to those seen on day 1 (P > 0.13). However, at the site of CSII, P(max) and TFR progressively increased with CSII duration. By the end of day 7, P(max) and TFR reached 25.8 */2.11 kPa (geometric mean */geometric standard deviation) and 8.64 */3.48 kPa*s/μL, respectively, representing a remarkable 3.5‐ and 20.6‐fold increase relative to the respective P(max) and TFR values observed on day 1 (P < 0.001). CONCLUSION: Our results suggest that insulin induces a progressive increase in the resistance of subcutaneous tissue to the introduction of fluid; this has important implications for the future design of insulin pumps and infusion sets. |
format | Online Article Text |
id | pubmed-9299465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-92994652022-07-21 Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy Regittnig, Werner Tschaikner, Mathias Tuca, Alexandru‐Cristian Simic, Amra Feiel, Jürgen Schaller‐Ammann, Roland Licht, Alexander H. Jungklaus, Miró Pieber, Thomas R. Diabetes Obes Metab Original Articles AIM: To determine the effect of insulin on the resistance of subcutaneous tissue to the flow of infusion fluids. MATERIALS AND METHODS: Thirty subjects with type 1 diabetes wore two Accu‐Chek Spirit Combo insulin pumps with Accu‐Chek FlexLink infusion sets (Roche Diabetes Care, Mannheim, Germany) for 7 days. One pump was filled with insulin aspart (Novo Nordisk, Bagsvaerd, Denmark) and used for continuous subcutaneous insulin infusion (CSII). The other pump was filled with insulin diluting medium (IDM; Novo Nordisk) and used to deliver IDM subcutaneously at rates identical to those employed for CSII. Both infusion sites were assessed daily by measuring the pressure required to infuse various bolus amounts of IDM. RESULTS: On day 1, maximum pressure (P(max)) and tissue flow resistance (TFR; calculated from measured pressure profiles) were similar for both infusion sites (P > 0.20). During the subsequent study days, the P(max) and TFR values observed at the IDM infusion site remained at levels comparable to those seen on day 1 (P > 0.13). However, at the site of CSII, P(max) and TFR progressively increased with CSII duration. By the end of day 7, P(max) and TFR reached 25.8 */2.11 kPa (geometric mean */geometric standard deviation) and 8.64 */3.48 kPa*s/μL, respectively, representing a remarkable 3.5‐ and 20.6‐fold increase relative to the respective P(max) and TFR values observed on day 1 (P < 0.001). CONCLUSION: Our results suggest that insulin induces a progressive increase in the resistance of subcutaneous tissue to the introduction of fluid; this has important implications for the future design of insulin pumps and infusion sets. Blackwell Publishing Ltd 2021-11-17 2022-03 /pmc/articles/PMC9299465/ /pubmed/34739179 http://dx.doi.org/10.1111/dom.14594 Text en © 2021 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Regittnig, Werner Tschaikner, Mathias Tuca, Alexandru‐Cristian Simic, Amra Feiel, Jürgen Schaller‐Ammann, Roland Licht, Alexander H. Jungklaus, Miró Pieber, Thomas R. Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy |
title | Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy |
title_full | Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy |
title_fullStr | Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy |
title_full_unstemmed | Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy |
title_short | Insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: Implications for insulin pump therapy |
title_sort | insulin induces a progressive increase in the resistance of subcutaneous tissue to fluid flow: implications for insulin pump therapy |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299465/ https://www.ncbi.nlm.nih.gov/pubmed/34739179 http://dx.doi.org/10.1111/dom.14594 |
work_keys_str_mv | AT regittnigwerner insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy AT tschaiknermathias insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy AT tucaalexandrucristian insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy AT simicamra insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy AT feieljurgen insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy AT schallerammannroland insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy AT lichtalexanderh insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy AT jungklausmiro insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy AT pieberthomasr insulininducesaprogressiveincreaseintheresistanceofsubcutaneoustissuetofluidflowimplicationsforinsulinpumptherapy |